Podcasts about Massachusetts General Hospital

Dr Jeremy S Abramson from Massachusetts General Hospital in Boston, Dr Jennifer Crombie from Dana-Farber Cancer Institute also in Boston and Dr Laurie H Sehn from the BC Cancer Centre for Lymphoid Cancer in Vancouver, British Columbia, Canada, discuss recent updates on available and novel treatment strategies for follicular lymphoma.  CE information and select publications here.

In this episode, Dr. Jagmeet Singh of Harvard Medical School and Massachusetts General Hospital and Dr. Sanjay Gandhi of Philips Healthcare Informatics discuss how AI, sensors, and digital tools are reshaping cardiovascular care. They share insights on moving from reactive to proactive care, improving efficiency, and empowering both clinicians and patients in an evolving healthcare landscape.This episode is sponsored by Philips EI.

When her husband was diagnosed with frontotemporal degeneration at just 29, Katie Brandt's life changed overnight. What began as confusion and heartbreak became a lifelong calling to transform how we see, support, and study dementia. Today, Katie is the Director of Caregiver Support Services and Public Relations at the Massachusetts General Hospital Frontotemporal Disorders Unit, and the Founder & CEO of Katie Brandt Advocacy. In this conversation, we talk about what it means to become a “caregiver detective”, the quiet observer, the record keeper, the advocate who pieces together the truth when something feels off. We explore how early and accurate diagnosis brings dignity, how research becomes more human when it includes caregiver voices, and why supporting caregivers isn't just compassionate, it's strategic. Katie shares the lessons she's learned through love, loss, and leadership, and how her belief that “love will end FTD” continues to guide her work and the families she serves.   To buys tickets and learn more about A Night with the Arts for FTD, an annual gala featuring the Sermos Memorial Art Show, benefitting the clinical research program in the MGH Frontotemporal Disorders Unit. Visit HERE. The MGH Frontotemporal Disorders Unit hosts From Care to Cure podcast. Listen HERE. Thank you to our Sponsor Zinnia TV is a therapeutic dementia care platform that supports caregivers. We are not medical professionals and are not providing any medical advice. If you have any medical questions, we recommend that you talk with a medical professional of your choice. willGather has taken care in selecting its speakers but the opinions of our speakers are theirs alone. Thank you for your continued interest in our podcasts. Please follow for updates, rate & review! For more information about our guest, podcast & sponsorship opportunities, visit www.willgatherpodcast.com

Send us a textDr. Kate Lund is a licensed clinical psychologist of 15 years, peak performance coach, best-selling author and TEDx speaker. Her specialized training in medical psychology includes world-renowned Shriners Hospital for Children, Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center, all of which are affiliated with Harvard Medical School. She uses a strengths-based approach to help her clients improve their confidence in school, sports and life while helping them to become more resilient and reach their full potential at all levels. She is also the author of Step Away: The Keys to Resilient Parenting and has a podcast called ”The Optimized Mind.”You can find Dr. Lund online at https://www.katelundspeaks.com/Dyslexia Journey has conversations and explorations to help you support the dyslexic child in your life. Content includes approaches, tips, and interviews with a range of guests from psychologists to educators to people with dyslexia. Increase your understanding and connection with your child as you help them embrace their uniqueness and thrive on this challenging journey!Send us your questions, comments, and guest suggestions to parentingdyslexiajourney@gmail.comAlso check out our YouTube channel! https://www.youtube.com/@ParentingDyslexiaJourney

Prof Meletios-Athanasios (Thanos) C Dimopoulos from Alexandra Hospital in Athens, Greece, Dr Hans Lee from Sarah Cannon Research Institute in Nashville, Tennessee, Dr Joseph Mikhael from City of Hope Cancer Center in Phoenix, Arizona, and Dr Noopur Raje from Massachusetts General Hospital in Boston discuss recent updates on available and novel treatment strategies for relapsed/refractory multiple myeloma.  CE information and select publications here.

In this episode of the Epigenetics Podcast, we talked with Mo Motamedi from the Center for Cancer Research at Massachusetts General Hospital about his work on RNA-mediated epigenetic regulation. The Interview starts with Dr. Motamedi sharing his personal journey into the realm of biology, sparked by a familial inclination towards science and a challenge to excel in a field that initially felt daunting. His passion was ignited during a genetics class, as he recognized the quantitative nature of the discipline amidst the evolution of modern techniques like qPCR and high-throughput sequencing. Dr. Motamedi goes on to articulate the importance of understanding the interplay between genetics and broader biological systems, emphasizing that an insightful grasp of evolution is vital for decoding cellular mechanisms. He reflects on his time in a postdoctoral lab under Danish Moazet, investigating RNA interference (RNAi) and its unexpected nuclear roles, contributing significantly to the understanding of how RNAi is involved in gene silencing via chromatin interaction. As his narrative unfolds, Dr. Motamedi provides deep insights into his own lab's work, which focuses on the establishment and maintenance of epigenetic states and their implications in cancer epigenetics. He discusses groundbreaking discoveries related to RNAi and heterochromatin, detailing experiments that unveil how specific proteins contribute to transcriptional and post-transcriptional gene silencing. A pivotal theme emerges: the complex dynamics of genome evolution and chromatin organization can be reshaped under various biological contexts, including the quiescent state of cells under stress. Moreover, the discussion traverses recent publications from Dr. Motamedi's lab, revealing how they identify long non-coding RNAs that function as silencers at centromeres, an essential mechanism that aids in the establishment of heterochromatin independently of RNAi. His findings advocate for the idea that well-structured genome organization can lead to more efficient gene regulation, which can also be crucial in therapeutic contexts for various cancers. References Motamedi, M. R., Hong, E. J., Li, X., Gerber, S., Denison, C., Gygi, S., & Moazed, D. (2008). HP1 proteins form distinct complexes and mediate heterochromatic gene silencing by nonoverlapping mechanisms. Molecular cell, 32(6), 778–790. https://doi.org/10.1016/j.molcel.2008.10.026 Joh, R. I., Khanduja, J. S., Calvo, I. A., Mistry, M., Palmieri, C. M., Savol, A. J., Ho Sui, S. J., Sadreyev, R. I., Aryee, M. J., & Motamedi, M. (2016). Survival in Quiescence Requires the Euchromatic Deployment of Clr4/SUV39H by Argonaute-Associated Small RNAs. Molecular cell, 64(6), 1088–1101. https://doi.org/10.1016/j.molcel.2016.11.020 Joh, R. I., Lawrence, M. S., Aryee, M. J., & Motamedi, M. (2021). Gene clustering drives the transcriptional coherence of disparate biological processes in eukaryotes. Systems Biology. https://doi.org/10.1101/2021.04.17.440292 Related Episodes Evolutionary Forces Shaping Mammalian Gene Regulation (Emily Wong) Chromatin Evolution (Arnau Sebé-Pedrós) The Role of lncRNAs in Tumor Growth and Treatment (Sarah Diermeier) Contact Epigenetics Podcast on Mastodon Epigenetics Podcast on Bluesky Dr. Stefan Dillinger on LinkedIn Active Motif on LinkedIn Active Motif on Bluesky Email: podcast@activemotif.com

Brett Owens, MD, Professor of Orthopaedic Surgery at the Brown University Alpert Medical School in Providence, Rhode Island and Editor-in-Chief of the American Journal of Sports Medicine, and Miho Tanaka, MD, PhD, Director of the Women's Sports Medicine Program at the Massachusetts General Hospital, Associate Professor of Orthopaedic Surgery at Harvard Medical School, and Associate Editor at the American Journal of Sports Medicine, discuss the exciting future of AJSM, challenges in patellofemoral care, women's sports medicine, their secret and not-so-secret talents, and more.

In this episode, Dr. Jagmeet Singh of Harvard Medical School and Massachusetts General Hospital and Dr. Sanjay Gandhi of Philips Healthcare Informatics discuss how AI, sensors, and digital tools are reshaping cardiovascular care. They share insights on moving from reactive to proactive care, improving efficiency, and empowering both clinicians and patients in an evolving healthcare landscape.This episode is sponsored by Philips EI.

NAD+ and Skin Longevity, featuring New Frontier Bio Co-Founder and Associate Professor in Dermatology at Harvard Medical School Dr. Anna Mandinova The anti-ageing beauty market is changing in response to consumer expectations and scientific progress. Skin biologists working in the cosmetics sector as well as medical professionals are studying ingredients that promise to optimize cell function and change what's possible with both topical treatments and beauty supplements.    This week on the CosmoFactory podcast, we discover the latest in dermatology science and skincare research with our guest Dr. Anna Mandinova, Co-Founder of New Frontier Bio, Associate Professor in Dermatology at Harvard Medical School, Director of the Harvard Stem Cell Institute Cutaneous Biology Program, and Associate Director of the Cutaneous Biology Research Center at Massachusetts General Hospital. If you appreciated this episode: FOLLOW the CosmoFactory podcast & please LEAVE US A REVIEW today. With your help, even more cosmetic industry professionals can discover the inspiring interviews we share on CosmoFactory! ABOUT CosmoFactoryBeauty industry stakeholders listen to the CosmoFactory podcast for inspiration and for up-to-date information on concepts, tactics, and solutions that move business forward. CosmoFactory – Ideas to Innovation is a weekly interview series for cosmetics and personal care suppliers, finished product brand leaders, retailers, buyers, importers, and distributors. Each Tuesday, CosmoFactory guests share experiences, insights, and exclusive behind-the-scenes details—which makes this not only a must-listen B2B podcast but an ongoing case study of our dynamic industry. Guests are actively working in hands-on innovation roles along the beauty industry supply chain; they specialize in raw materials, ingredients, manufacturing, packaging, and more. They are designers, R&D or R&I pros, technical experts, product developers, key decision makers, visionary executives. HOST Deanna UtroskeCosmetics and personal care industry observer Deanna Utroske hosts the CosmoFactory podcast. She brings an editorial perspective and a decade of industry expertise to every interview. Deanna is also Editor of the Beauty Insights newsletter and a supply-side positioning consultant. She writes the Global Perspectives column for EuroCosmetics magazine, is a former Editor of CosmeticsDesign, and is known globally for her ability to identify emerging trends, novel technologies, and true innovation in beauty. A PRODUCTION OF Cosmoprof Worldwide BolognaCosmoFactory is the first podcast from Cosmoprof Worldwide Bologna, taking its place among the best B2B podcasts serving the global beauty industry.   Cosmoprof Worldwide Bologna is the most important beauty trade show in the world. Dedicated to all sectors of the industry, Cosmoprof Worldwide Bologna welcomes over 250,000 visitors from 150 countries and regions and nearly 3,000 exhibitors to Bologna, Italy, each year. It's where our diverse and international industry comes together to build business relationships and to discover the best brands and newest innovations across consumer beauty, professional beauty, and the entire supply chain. The trade show includes a robust program of exclusive educational content, featuring  executives and key opinion leaders from every sector of the cosmetics, fragrance, and personal care industry. Cosmoprof Worldwide Bologna is the most important event of the Cosmoprof international network, with exhibitions in Asia (Hong Kong), the US (Las Vegas and Miami), India (Mumbai) and Thailand (Bangkok). Thanks to its global exhibitions Cosmoprof connects a community of more than 500,000 beauty stakeholders and 10,000 companies from 190 countries and regions. Learn more today at Cosmoprof.com    

Join Elizabeth M. Bauer, MD, FACP, FACE, Dipl ABOM, as she interviews Nicholas A. Tritos, MD, DSc, Professor of Clinical Medicine at Harvard Medical School and faculty of the Neuroendocrine Unit/Neuroendocrine and Pituitary Tumor Clinical Center at Massachusetts General Hospital, about his Endocrine Practice article, Impulse Control Disorders in Patients with Hyperprolactinemia on Dopamine Agonist Therapy – How Concerned Should We Be? The conversation explores the prevalence and risk factors for impulse control disorders, underlying biological mechanisms, clinical screening strategies, and approaches to patient counseling and management. Read the full article in the July 2025 issue of Endocrine Practice here: https://doi.org/10.1016/j.eprac.2025.04.018

"We may worry we'll say the wrong thing and worsen someone's hopelessness. We may think depression is a medical condition outside our scope or assume sufferers will reach out if they desire help. Uncertain how to act, many don't act at all, lapsing into silence and avoidance." Today's show will take a look at technology as we walk through chapter 8 of Andrew and Christian Walker's new book, "What Do I Say When...?: A Parents' Guide to Navigating Cultural Chaos for Children & Teens." Bring your questions! There will be time for Q&A and callers! Kathryn Butler (MD, Columbia University) is a trauma surgeon who retired from practice at Massachusetts General Hospital. She is the author of numerous works on medical topics from a Christian perspective, appearing on Desiring God, the Gospel Coalition, and Christianity Today. She authored today's book, "What Does Depression Mean for My Faith?" that is part of the TGC Hard Questions series.

In this episode of Deep Cuts: Exploring Equity in Surgery, Dr. Brandon Baird provides an overview of ENT, or ear, nose, and throat surgery. We discuss key aspects of the specialty, from management of polyps to advanced head and neck cancers. We also touch on disparities in cancer care and the importance of speech and swallow pathologists. Finally, we examine which populations lack access to ENT care and the reasons behind these barriers.Brandon Jackson Baird, MD, is a laryngeal surgeon specializing in a wide range of laryngeal diseases with an emphasis on medical and surgical management of voice and swallowing disorders.  He completed residency in Otolaryngology-Head and Neck Surgery at Stanford University and fellowship at Harvard University – Massachusetts General Hospital.As a trained singer himself, Dr. Baird understands the importance of expert laryngeal care, and he has the skill and experience to treat professional voice artists for voice conditions. Dr. Baird has a subspecialty focus in medical and surgical management for singers with phonotraumatic vocal fold pathology, like nodules and polyps. While at Massachusetts General Hospital, he also trained under Dr. Steven Zeitels, the laryngeal surgeon credited with treating professional performers Steven Tyler, Sam Smith and Adele. As a dedicated researcher, Dr. Baird is identifying and developing novel biotechnology within the field of laryngeal surgery. Additionally, Dr. Baird is evaluating and investigating minimally invasive treatment options for early laryngeal cancerDeep Cuts: Exploring Equity in Surgery comes to you from the Department of Surgery at the University of Chicago, which is located on Ojibwe, Odawa and Potawatomi land.Our senior production coordinator is Nihar Rama. Our production team also includes Beryl Zhou and Daniel Correa Bucio. Our senior editors are Alia Abiad, Caroline Montag, and Chuka Onuh. Our editorial team also includes Megan Teramoto and Ria Sood. The intro song you hear at the beginning of our show is “Love, Money Part 2” from Chicago's own Sen Morimoto off of Sooper Records. Our cover art is from Leia Chen. Special thanks to Tony Liu, our founding producer/editor.If you've liked this podcast, please leave a rating, comment, and review wherever you get your podcasts. Please reach out to us as well — let us know what have you most enjoyed about our podcast, and where you see room for improvement. You can reach out to us on Instagram @deepcutssurgery. Find out more about our work at deepcuts.surgery.uchicago.edu.

Send us a textIn this podcast episode, a pediatric gastroenterologist, Pediatric GI expert Dr. Victoria Martin joins me to demystify milk intolerance in babies—what FPIAP and cow's milk protein intolerance really mean, why these diagnoses are tricky, and how families can find practical, evidence-based solutions.shares her expertise on milk intolerances in infants. Dr. Martin emphasizes the importance of supporting breastfeeding mothers, addressing misconceptions about milk allergies, and the potential benefits of early allergen exposure. Additionally, Dr. Martin and the host discuss the role of lactose intolerance, and nutritional considerations for infants. Dr. Victoria (Tori) Martin is an Assistant Professor of Pediatrics at Harvard Medical School, Co-Director of the Pediatric Gastroenterology Section of the Food Allergy Center at Massachusetts General Hospital for Children, and Associate Program Director of the MGHfC Pediatric GI Fellowship. Her research focuses on early-life GI health, food antigens, and the infant microbiome.Key takeaways“Lactose intolerance” is not a typical infant diagnosis; infant concerns are usually protein related.Microscopic stool blood alone has limits—treat the baby, not just the test.For breastfed infants with visible blood and discomfort, consider short, targeted milk-protein elimination, then a re-challenge in ~1 month to confirm diagnosis and avoid unnecessary long-term restriction.Hypoallergenic formulas are an option; prioritize growth, feeding comfort, and family well-being.Early, safe introduction of other allergens (e.g., peanut, egg) should still proceed on schedule unless otherwise directed by your clinician.Your Child is Normal is the trusted podcast for parents, pediatricians, and child health experts who want smart, nuanced conversations about raising healthy, resilient kids. Hosted by Dr. Jessica Hochman — a board-certified practicing pediatrician — the show combines evidence-based medicine, expert interviews, and real-world parenting advice to help listeners navigate everything from sleep struggles to mental health, nutrition, screen time, and more. Follow Dr Jessica Hochman:Instagram: @AskDrJessica and Tiktok @askdrjessicaYouTube channel: Ask Dr Jessica If you are interested in placing an ad on Your Child Is Normal click here or fill out our interest form.-For a plant-based, USDA Organic certified vitamin supplement, check out : Llama Naturals Vitamin and use discount code: DRJESSICA20-To test your child's microbiome and get recommendations, check out: Tiny Health using code: DRJESSICA The information presented in Ask Dr Jessica is for general educational purposes only. She does not diagnose medical conditi...

En pleine vacances, c'est parfois difficile de reconnecter ses neurones. Pour aider son cerveau à se remettre en route, il est possible de miser sur son assiette pour donner un petit coup de pouce. L'alimentation joue un rôle capital sur le cerveau. Certains nutriments participent à la fluidité et la communication entre les neurones. Dans un article publié sur son blog, la docteure Uma Naidoo, directrice du service de psychiatrie nutritionnelle au Massachusetts General Hospital, livre ses cinq aliments préférés pour chouchouter le cerveau.  Quels sont-ils ? Pourquoi sont-ils bénéfiques au cerveau ? Écoutez la suite de cet épisode de "Maintenant Vous Savez - Santé". Un podcast Bababam Originals, écrit et réalisé par Olivia Villamy. Première diffusion : 5 septembre 2023 À écouter aussi : Quelle est l'heure idéale pour faire l'amour ? Peut-on vraiment soigner avec du venin d'abeilles ? Quels sont les métiers les plus menacés par l'Intelligence Artificielle ? Retrouvez tous les épisodes de ⁠⁠"Maintenant vous savez".⁠⁠ Suivez Bababam sur ⁠⁠Instagram⁠⁠. Learn more about your ad choices. Visit megaphone.fm/adchoices

In this SEE YOU NOW Insight, nurse leaders Gaurdia Banister, PhD, RN, NEA-BC, FAAN, and Hiyam Nadel, MBA, CCG RN, share how the Ether Dome Challenge at Massachusetts General Hospital is using open innovation to surface frontline solutions and strengthen care delivery. Against a backdrop of persistent nurse staffing shortages and a global talent emergency, they show how including every role group in innovation, and ensuring leadership engagement, communication, and follow-through, creates a culture where staff feel heard, valued, and supported. Innovation, they remind us, isn't just about solving problems; it's about caring for patients and caregivers, and building strong systems for the future.      To listen to this Insight clip's full episode visit SEE YOU NOW Podcast Episode 77: Fostering a Culture of Inquiry at APPLE, SPOTIFY, or YOUTUBE or at your favorite streaming platform. For more information on the podcast bundles visit ANA's Innovation Website at https://www.nursingworld.org/practice-policy/innovation/education.  Have questions or feedback for the SEE YOU NOW team?  Future episode ideas? Contact us at hello@seeyounowpodcast.com.  

In this episode, I dive into the complexities of autoimmunity and the gut-brain axis with Dr. Datis Kharrazian, one of the leading voices in functional medicine. What strikes me about our conversation is how he connects the dots between environment, genetics, and lifestyle, painting a clear picture of why autoimmune diseases are on the rise and why they're so difficult to treat. Dr. Kharrazian breaks down how and why the immune system malfunctions, and more importantly, how lifestyle adaptations can play a pivotal role in managing these conditions. Together, we explore the principles of functional medicine and how they reshape chronic disease care, while also looking at the latest insights into the gut microbiome, its impact on brain health, and the links to conditions like Alzheimer's and long COVID. This episode is packed with professional insights, practical takeaways, and a vision of how functional medicine can transform patient care in today's world. Key Takeaways: Autoimmunity occurs when the immune system mistakenly attacks the body's own tissues, with factors such as environmental exposure and genetic susceptibility being key contributors. Functional medicine prioritizes enhancing bodily functions rather than simply inhibiting disease symptoms, offering a promising approach for managing chronic diseases. Lifestyle factors like sleep, stress management, and exercise play a crucial role in managing autoimmune conditions and maintaining overall health. The gut-brain axis is integral to understanding and treating neurological conditions, with bidirectional communication between these systems influencing health outcomes. Precision diagnostics and individualized care models are essential for effective functional medicine practice, emphasizing the need for education in the field. Dr. Datis Kharrazian is a clinical research scientist, academic professor, and a functional medicine healthcare provider. He is an Associate Clinical Professor at Loma Linda University School of Medicine. Dr. Kharrazian earned a PhD in Health Science with concentrations in immunology and toxicology, and a Doctor of Health Science degree from Nova Southeastern University. He also holds a Master of Science degree in Human Nutrition from the University of Bridgeport, a Doctor of Chiropractic degree from Southern California University of Health Sciences, and a Master of Medical Sciences degree in Clinical Investigation from Harvard Medical School. Dr. Kharrazian completed his post-doctoral research training at Harvard Medical School and Massachusetts General Hospital. He was a researcher at Harvard Medical School for seven years. Currently, he serves as the academic director of the Kharrazian Institute and the Academy of Functional Nutrition and Lifestyle Medicine. Website The Academy of Functional Nutrition and Lifestyle Medicine Instagram Connect with me! Website Instagram Facebook YouTube

The power of empathy for organizational success is not just proven in all the data. Neuroscience backs up our human need to connect and form relationships. But why does empathic communication lead to better business results, improved wellness, decreased burnout, and better workforce retention? We explore that today with Dr. Helen Riess. Persuaded by the belief that empathy can transform healthcare, Dr. Riess founded Empathetics to meet medicine's most pressing challenges. We talk about whether empathy can be taught or if it's an inborn trait, the evidence for how empathy improves measurable outcomes, and what shifts we need to make to more fully bring empathy into work. Dr. Riess shares how the brain works on empathy and how it looks different for different people of all abilities. Finally, we discuss the importance of getting people into the right seat to lead with empathy and why self-regulation skills are critical to leadership success.To access the episode transcript, please scroll down below.Listen and discover:Why empathy is a key survival trait of the human species.Effective shifts to bring more personal compassion, kindness, and empathy to the workplace.The best ways to start your day for effective, empathetic leadership.Advice for dealing with people at different stages and levels of empathy.Why practicing empathy at work spills over into other aspects of your life. "Neuroscience shows that when the brain is at rest, we're not doing nothing. The default mode is all about working out relationships. It just shows how critical human relationship and connectedness really is." — Dr. Helen RiessFrom Our Partner:SparkEffect partners with organizations to unlock the full potential of their greatest asset: their people. Through their tailored assessments and expert coaching at every level, SparkEffect helps organizations manage change, sustain growth, and chart a path to a brighter future.Go to sparkeffect.com/edge now and download your complimentary Professional and Organizational Alignment Review today.About Dr. Helen Riess, Founder and Chief Medical Officer, EmpatheticsDr. Helen Riess, a psychiatrist at Massachusetts General Hospital and an Associate Professor of Psychiatry at Harvard Medical School, is renowned for her groundbreaking research into the neurobiology of empathy. Dr. Riess has shown that empathy can be taught and learned. Her work has reshaped how healthcare professionals connect with patients and colleagues, fostering trust and greater patient and clinician satisfaction. Her award-winning research has been published in leading peer-reviewed journals.Persuaded by the belief that empathy can transform healthcare, Dr. Riess founded Empathetics to meet medicine's most pressing challenges. As Chief Medical Officer, she translates her research into programs that help healthcare teams navigate the communication demands of modern practice. Her empathy training programs improve wellness, reduce burnout and employee turnover, and improve workforce cultures.Her best-selling book, The Empathy Effect, has resonated globally. Her TEDx talk, “The Power of Empathy,” has nearly one million views. A Founding Member of Newsweek's Expert Forum, Dr. Riess continues to champion the transformative power of empathy to improve healthcare for everyone.Connect with Helen: Empathetics, Inc: empathetics.comInstagram: instagram.com/helen.riessLinkedIn: linkedin.com/in/helen-riessTEDx: The Power of EmpathyBook: The Empathy Effect: empathetics.com/empathy-effect-bookConnect with Maria:Get Maria's books on empathy: Red-Slice.com/booksLearn more about Maria's work: Red-Slice.comHire Maria to speak: Red-Slice.com/Speaker-Maria-RossTake the LinkedIn Learning Course! Leading with EmpathyLinkedIn: Maria RossInstagram: @redslicemariaFacebook: Red SliceThreads: @redslicemaria

Dr. Kathleen Horst, Dr. Rachel Jimenez, and Dr. Yara Abdou discuss the updated guideline from ASTRO, ASCO, and SSO on postmastectomy radiation therapy. They share new and updated recommendations on topics including PMRT after upfront surgery, PMRT after neoadjuvant systemic therapy, dose and fractionation schedules, and delivery techniques. They comment on the importance of a multidisciplinary approach and providing personalized care based on individual patient characteristics. Finally, they review ongoing research that may impact these evidence-based guidelines in the future. Read the full guideline, “Postmastectomy Radiation Therapy: An ASTRO-ASCO-SSO Clinical Practice Guideline” at www.asco.org/breast-cancer-guidelines" TRANSCRIPT This guideline, clinical tools, and resources are available at www.asco.org/breast-cancer-guidelines. Read the full text of the guideline and review authors' disclosures of potential conflicts of interest in the Journal of Clinical Oncology, https://ascopubs.org/doi/10.1200/JCO-25-01747  Brittany Harvey: Hello and welcome to the ASCO Guidelines podcast, one of ASCO's podcasts delivering timely information to keep you up to date on the latest changes, challenges, and advances in oncology. You can find all the shows, including this one, at asco.org/podcasts. My name is Brittany Harvey, and today I am interviewing Dr. Kathleen Horst, expert panel chair from Stanford University; Dr. Rachel Jimenez, expert panel vice chair from Massachusetts General Hospital; and Dr. Yara Abdou, ASCO representative from the University of North Carolina, authors on "Postmastectomy Radiation Therapy: An American Society for Radiation Oncology, American Society of Clinical Oncology, and Society of Surgical Oncology Clinical Practice Guideline." Thank you for being here today, Dr. Horst, Dr. Jimenez, and Dr. Abdou. Dr. Kathleen Horst: Thank you for having us. Brittany Harvey: And then just before we discuss this guideline, I would like to note that ASCO takes great care in the development of its guidelines and ensuring that the ASCO conflict of interest policy is followed for each guideline. The disclosures of potential conflicts of interest for the guideline panel, including Dr. Horst, Dr. Jimenez, and Dr. Abdou who have joined us here today, are available online with the publication of the guideline in the Journal of Clinical Oncology, which is linked in the show notes. Then to dive into the content that we are here today to talk about, Dr. Horst, could you start us off by describing what prompted the update for this joint guideline between ASTRO, ASCO, and SSO, and what is the scope of this 2025 guideline on postmastectomy radiation therapy? Dr. Kathleen Horst: Thank you. This joint guideline was last updated in 2016. Over the past decade, the treatment of breast cancer has evolved substantially. Newer systemic therapy regimens have increasingly personalized treatment based on tumor biology, and local therapy management has explored both the de-escalation of axillary surgery and more abbreviated courses of radiation therapy. Given these advances, it was important to revisit the role of postmastectomy radiotherapy in this modern era of breast cancer therapy. This updated guideline addresses four key questions, including postmastectomy radiation therapy after upfront surgery as well as after neoadjuvant systemic therapy. It also reviews the evolving role of various dose and fractionation schedules and optimal treatment techniques and dose constraints. Brittany Harvey: Excellent. I appreciate that background, Dr. Horst. So then, next, Dr. Jimenez, I would like to review the recommendations of this guideline across those four key questions that Dr. Horst just mentioned. So first, what does the panel recommend for PMRT for patients who received initial treatment with mastectomy? Dr. Rachel Jimenez: The panel provided pretty strong consensus that patients with positive lymph nodes or patients with large tumors involving the skin or the chest wall should receive postmastectomy radiation. However, the panel also recognized that the omission of postmastectomy radiation may be appropriate for select patients who have positive lymph nodes and have an axillary lymph node dissection if they have a low nodal burden and other favorable clinical or pathologic features. For patients without lymph node involvement at the time of surgery and no involvement of the skin or chest wall, postmastectomy radiation was not advised by the panel. Brittany Harvey: Understood. It is helpful to understand those recommendations for that patient population. Following that, Dr. Abdou, what are the key recommendations for PMRT for patients who received neoadjuvant systemic therapy before mastectomy? Dr. Yara Abdou: When we think about PMRT after neoadjuvant treatment, the key point is that the initial stage of presentation still matters a lot. So for example, if a patient comes in with more advanced disease, say a large primary tumor, like a clinical T4, or more extensive nodal disease, like an N2 or N3 disease, those patients should get PMRT, no matter how well they respond to neoadjuvant therapy, because we know it reduces the risk of recurrence and that has been shown pretty consistently. On the other hand, if there are still positive lymph nodes after neoadjuvant treatment, basically residual nodal disease, PMRT is also strongly recommended because the risk of local-regional recurrence is much higher in that setting. The gray area is the group of patients who start with a lower burden of nodal disease, such as N1 disease, but then become node negative at surgery. For those patients, we tend to individualize the decision. So if the patient is young or has triple-negative disease, or if there is a lot of residual disease in the breast even though the nodes are cleared, then radiation is probably helpful. But if everything has melted away with pCR in both the breast and the nodes, then it may be safe to omit PMRT in those patients. For patients with smaller tumors and no nodal involvement to begin with, like a clinical T1-T2 N0, if they are still node negative after neoadjuvant treatment, then PMRT is generally not recommended because their baseline recurrence risk is low. And finally, if the margins are positive and cannot be re-excised, then PMRT is recommended after neoadjuvant therapy. Brittany Harvey: Yes, those distinctions are important for appropriate patient selection. So then, Dr. Horst, we have just reviewed the indications for PMRT, but for those patients who receive PMRT, what are the appropriate treatment volumes and dose fractionation regimens? Dr. Kathleen Horst: The guideline addresses coverage of the chest wall and regional nodes with a specific discussion of the data regarding internal mammary nodal irradiation, which has been an area of controversy over many years. The guideline also reviews the data exploring moderate hypofractionation, or shorter courses of radiation therapy. The task force recommends utilizing moderate hypofractionation for the majority of women requiring postmastectomy radiation, which is likely to have a large impact on clinical practice. This recommendation is based on the evolving data demonstrating that a 3-week course of radiotherapy after mastectomy provides similar oncologic outcomes and minimal toxicity for most patients compared to the standard 5-week treatment course. Brittany Harvey: Thank you for reviewing that set of recommendations as well. So then, Dr. Jimenez, to wrap us up on the key questions here, what delivery techniques are recommended for treating patients who receive PMRT? Dr. Rachel Jimenez: So this portion of the guideline is likely to be most helpful for radiation oncologists because it represents the most technical part of the guideline, but we do believe that it offers some important guidance that has, to this point, been lacking in the postmastectomy radiation setting. So first, the panel recommends that all patients should undergo 3-dimensional radiation planning using CAT scan based imaging, and this includes contouring. So contouring refers to the explicit identification, using a drawing interface on the CAT scan imaging, by the radiation oncologist to identify the areas that are targeted to receive radiation, as well as all of the nearby normal tissues that could receive unintended radiation exposure. And we also provide radiation oncologists in the guideline with suggestions about how much dose each target tissue should receive and what the dose limits should be for normal tissues. Additionally, we make some recommendations regarding the manner in which radiation is delivered. So for example, we advise that when conventional radiation methods are not sufficient for covering the areas of the body that are still at risk for cancer, or where too high of a dose of radiation would be anticipated to a normal part of the body, that providers employ a technique called intensity modulated radiation therapy, or IMRT. And if IMRT is going to be used, we also advise regular 3-dimensional imaging assessments of the patient's body relative to the treatment machine to ensure treatment fidelity. When the treatments are delivered, we further advise using a deep inspiration breath-hold technique, which lowers the exposure to the heart and to the lungs when there is concern for cardiopulmonary radiation exposure, and again, that image guidance be used along with real-time monitoring of the patient's anatomy when those techniques are employed. And then finally, we advise that patients receiving postmastectomy radiation utilize a bolus, or a synthetic substance placed on the patient's skin to enhance radiation dose to the superficial tissue, only when there is involvement of the skin with cancer or other high-risk features of the cancer, but not for every patient who receives postmastectomy radiation. Brittany Harvey: Understood. And then, yes, you just mentioned that section of the guideline is probably most helpful for radiation oncologists, but I think you can all comment on this next question. What should all clinicians, including radiation oncologists, surgical oncologists, medical oncologists, and other oncologic professionals, know as they implement all of these updated recommendations? Dr. Rachel Jimenez: So I think one of the things that is most important when we consider postmastectomy radiation and making recommendations is that this is a multidisciplinary panel and that we would expect and encourage our colleagues, as they interpret the guidelines, to employ a multidisciplinary approach when they are discussing each individual patient with their surgical and medical oncology colleagues, that there is no one size fits all. So these guidelines are intended to provide some general guidance around the most appropriate techniques and approaches and recommendations for the utilization of postmastectomy radiation, but that we recognize that all of these recommendations should be individualized for patients and also represent somewhat of a moving target as additional studies, both in the surgical and radiation oncology realm as well as in the systemic therapy realm, enter our milieu, we have to adjust those recommendations accordingly. Dr. Kathleen Horst: Yeah, I would agree, and I wanted to comment as a radiation oncologist, we recognize that local-regional considerations are intertwined with systemic therapy considerations. So as the data evolve, it is critical to have these ongoing updates in a cross-disciplinary manner to ensure optimal care for our patients. And as Dr. Jimenez mentioned, these multidisciplinary discussions are critical for all of us to continue to learn and understand the evolving recommendations across disciplines but also to individualize them according to individual patients. Dr. Yara Abdou: I could not agree more. I think from a medical oncology perspective, systemic therapy has gotten much better with adjuvant CDK4/6 inhibitors, T-DM1, capecitabine, and immune therapy. So these are all newer adjuvant therapies, so the baseline recurrence risks are lower than what they were in the trials that established PMRT. So the absolute benefit of radiation varies more now, so smaller for favorable biology but still relevant in aggressive subtypes or with residual disease. So it is definitely not a one-size-fits-all. Brittany Harvey: Yes, I think it is important that you have all highlighted that multidisciplinary approach and having individualized, patient-centric care. So then, expanding on that just a little bit, Dr. Abdou, how will these guideline recommendations affect patients with breast cancer? Dr. Yara Abdou: So basically, reiterating what we just talked about, these guidelines really move us towards personalized care. So for patients at higher risk, so those with larger tumors, multiple positive nodes, or residual nodal disease after neoadjuvant therapy, PMRT remains essential, consistently lowering local-regional recurrence and improving survival. But for patients at intermediate or lower risk, the recommendations support a more selective approach. So instead of a blanket rule, we now integrate tumor biology, response to systemic therapy, and individual patient factors to decide when PMRT adds meaningful benefit. So the impact for patients is really important because those at high risk continue to get the survival advantage of radiation while others can be spared the unnecessary treatment and side effects. So in short, we are aligning PMRT with modern systemic therapy and biology, making sure each patient receives the right treatment for their situation. Brittany Harvey: Absolutely. Individualizing treatment to every patient will make sure that everyone can achieve the best outcomes as possible. So then, Dr. Jimenez, to wrap us up, I believe Dr. Horst mentioned earlier that data continues to evolve in this field. So in your opinion, what are the outstanding questions regarding the use of PMRT and what are you looking to for the future of research in this space? Dr. Rachel Jimenez: So there are a number of randomized phase III clinical trials that are either in active accrual or that have reported but not yet published that are exploring further de-escalation of postmastectomy radiation and of axillary surgery. And so we do not yet have sufficient data to understand how those two pieces of information integrate with each other. So for example, if you have a patient who has a positive lymph node at the time of diagnosis and forgoes axillary surgery aside from a sentinel lymph node biopsy, we do not yet know that we can also safely forgo radiation entirely in that setting. So we expect that future studies are going to address these questions and understand when it is appropriate to simultaneously de-escalate surgery and radiation. Additionally, there is a number of trials that are looking at ways in which radiation could be omitted or shortened. So there is the RT CHARM trial, which has reported but not yet published, looking at a shorter course of radiation. And so we do make recommendations around that shorter course of radiation in this guideline, but we anticipate that the additional data from the RT CHARM study will provide further evidence in support of that. Additionally, there is a study called the TAILOR RT trial, which looks at forgoing postmastectomy radiation in patients who, to Dr. Abdou's point, have a favorable tumor biology and a low 21-gene recurrence score. And so we are going to anticipate the results from that study to help guide who can selectively forgo postmastectomy radiation when they fall into that favorable risk category. So there are a number of questions that I think will help flesh out this guideline. And as they publish, we will likely publish a focused update on that information to help provide context for our colleagues in the field and clarify some of these recommendations to suit the latest data. Brittany Harvey: Absolutely. We will look forward to those de-escalation trials and ongoing research in the field to build on the evidence and look for future updates to this guideline. So I want to thank you for your work to update these guidelines, and thank you for your time today, Dr. Horst, Dr. Jimenez, and Dr. Abdou. Dr. Rachel Jimenez: Thank you. Dr. Yara Abdou: Thank you. Dr. Kathleen Horst: Thank you. Brittany Harvey: And then finally, thank you to all of our listeners for tuning in to the ASCO Guidelines podcast. To read the full guideline, go to www.asco.org/breast-cancer-guidelines. You can also find many of our guidelines and interactive resources in the free ASCO Guidelines app, which is available in the Apple App Store or the Google Play Store. If you have enjoyed what you have heard today, please rate and review the podcast and be sure to subscribe so you never miss an episode. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.  

Darshali Vyas is a pulmonary and critical care fellow at Massachusetts General Hospital. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. D.A. Vyas, L.G. Eisenstein, and D.S. Jones. The Race-Correction Debates — Progress, Tensions, and Future Directions. N Engl J Med 2025;393:1029-1036.

Joining me is Dr. Stuart Ablon, a psychologist, Harvard Medical School professor, founder and director of Think:Kids at Massachusetts General Hospital, and author of several books, including Changeable: How Collaborative Problem Solving Changes Lives at Home, at School, and at Work.   Together we explore:   Why kids' struggles are more about lagging skills than lack of motivation. The importance of empathy, co-regulation, and relationship-building in reducing conflict. The 3 “plans” parents can choose from when kids aren't meeting expectations—and how to use them effectively. How Collaborative Problem Solving offers a structured yet compassionate alternative to “tough love” or “gentle parenting.” Practical ways to use this approach proactively and in the heat of the moment. How practicing this method not only improves behavior, but also fosters resilience, flexibility, and stronger parent–child bonds.   Whether you're a parent, teacher, or clinician, this conversation offers practical tools and a fresh perspective to help you support kids with understanding, structure, and collaboration   LEARN MORE ABOUT MY GUEST:

In episode 56 of Going anti-Viral, Dr Steven Grinspoon joins host Dr Michael Saag to discuss managing cardiovascular health in people with HIV. Dr Grinspoon is a clinician in the Neuroendocrine and Pituitary Tumor Clinical Center and faculty member at the Massachusetts General Hospital, and a Professor of Medicine at Harvard Medical School. He is a clinical researcher who studies hypothalamic control of body weight and fat distribution in obesity and lipodystrophy with a focus on the metabolic and cardiovascular consequences of visceral fat accumulation. Dr Grinspoon provides an overview of cardiovascular disease in people with HIV including a review of the REPRIEVE study that evaluated if statin medication is effective to prevent heart disease among people with HIV. Dr Saag and Dr Grinspoon detail the REPRIEVE study results demonstrating that statins lower baseline low-density lipoprotein (LDL) cholesterol levels and discuss the cardiovascular health benefits of lowering LDL cholesterol levels. They discuss arterial plaque, how it is measured and whether plaque can regress individuals on statins. Finally, Dr Saag and Dr Grinspoon discuss goals for follow-up studies to REPRIEVE and other studies looking into the benefits of statins in other populations.0:00 – Introduction1:28 – Overview of cardiovascular disease in people with HIV 3:23 – Overview of the REPRIEVE study, which evaluated if statin medication is effective to prevent heart disease among people with HIV10:51 – REPRIEVE study results lowering baseline LDL cholesterol                       13:26 – Follow-up studies in people who do not have HIV16:20 – How plaque is measured in the arteries19:40 – Regression of plaque in patients using statins 21:15 – Top goals for follow-up studies to REPRIEVEResources: REPRIEVE Study: https://www.reprievetrial.org/ __________________________________________________Produced by IAS-USA, Going anti–Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections. Going anti-Viral's host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences. Email podcast@iasusa.org to send feedback, show suggestions, or questions to be answered on a later episode.Follow Going anti-Viral on: Apple Podcasts YouTubeXFacebookInstagram...

Episode 061 | Arisa E. Ortiz, MD is the Founder/Creator of Your Pre-Visit, Director of Laser and Cosmetic Dermatology, and a Clinical Professor of Dermatology at the University of California, San Diego. She received training in Mohs Micrographic Surgery at UC San Diego and also completed the prestigious cosmetic and laser fellowship at Massachusetts General Hospital, Harvard Medical School, and Wellman Center for Photomedicine. Dr. Ortiz completed her dermatology residency training at UC Irvine and Beckman Laser Institute. She has authored over sixty publications and several book chapters. Dr. Ortiz also coedited a textbook on surgical reconstruction. She has presented at international and national conferences and is frequently an invited speaker at the American Academy of Dermatology (AAD), American Society for Dermatologic Surgery (ASDS), and the American Society for Laser Medicine and Surgery (ASLMS). She is on the editorial board of the Journal of Lasers in Surgery and Medicine and has won several awards including the ASLMS Dr. Horace Furumoto Young Investigator Award and ASLMS Best of Session Award for Cutaneous Applications, ASDS President's Outstanding Service Award, Castle Connolly Top Doctors Award, Exceptional Women in Medicine, and Newsweek America's Best Dermatologists. She has also been featured on The Doctors & Dr. Pimple Popper. Dr. Ortiz has served as the President of the San Diego Dermatologic Surgery Society and President of ASLMS. Her research interests are in laser treatment of non-melanoma skin cancer.This episode was recorded on March 24th, 2025.Connect with and learn from Dr. Rubin and SEENArisa Ortiz, MD (arisaortiz@gmail.com)Dr. Ortiz on IGYour Pre-Visit (Use code DERM60 for an extended free trial!)YPV on IGMore from Dr. Lewellis and Above & Beyond DermatologyNeed a dermatologist? Fill out this short interest form, text or call me at 715-391-9774, or email me at drlewellis@aboveandbeyondderm.com if you'd like to have a no obligation discovery call. I offer in-office visits, house calls, and virtual care in Wisconsin and virtual care in Illinois, Nebraska, and Colorado.Have an idea for a guest or want to be on the show yourself? Send me a text or email, and we'll see if it's a good fit.Above & Beyond DermatologyNutrafol -- special pricing and physician exclusive productsNeoGenesis -- my favorite source of stem cell released molecules for skin/hairSilagen.biz -- physician dispensed scar refinement products delivered to your door (use practice code 1206240832P)NewsletterLinkedInFacebookDr. Lewellis on InstagramAbove & Beyond Dermatology on InstagramYouTubeTikTokTwitter/XChange Your Mind, Change Your LifeSoMeDocs (Doctors on Social Media)Pippa!

You are in for a dose of inspiration in this episode of Raise the Line as we introduce you to a rare disease patient who was a leading force in establishing the diagnosis for her own condition, who played a key role in launching the first phase three clinical trials for it, and who is now coordinating research into the disease and related disorders at one of the nation's top hospitals. Rebecca Salky, RN, was first afflicted at the age of four with MOGAD, an autoimmune disorder of the central nervous system that can cause paralysis, vision loss and seizures. In this fascinating conversation with host Lindsey Smith, Rebecca describes her long and challenging journey with MOGAD, her work at the Neuroimmunology Clinic and Research Lab at Massachusetts General Hospital, and the importance of finding a MOGAD community in her early twenties. “There's a sense of power and security when you have others on your side. You're not alone in this journey of the rare disease,” she explains. Be sure to stay tuned to learn about Rebecca's work in patient advocacy, her experience as a nurse, and the three things she thinks are missing in the care of rare disease patients as our Year of the Zebra series continues.Mentioned in this episode:The MOG ProjectNeuroimmunology Clinic & Research Lab at Mass General If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast

In today's episode, we passed the mic to Tara E. Seery, MD, who moderated an OncLive Insights discussion on the future of the pancreatic cancer treatment paradigm. Rounding out the discussion with additional expert perspectives were Paul E. Oberstein, MD, and Priyadarshini Pathak, MBBS. Seery is a medical oncologist at the Hoag Family Cancer Institute in Newport Beach, California. Oberstein is an associate professor in the Department of Medicine at the New York University (NYU) Grossman School of Medicine; as well as the director of the Gastrointestinal Medical Oncology Program, the assistant director of the Pancreatic Cancer Center, and the service chief of the Gastrointestinal Medical Oncology Program at NYU Langone's Perlmutter Cancer Center. Pathak is an assistant in medicine at Massachusetts General Hospital and an instructor in medicine at Harvard Medical School in Boston.  In this exclusive conversation, Drs Seery, Oberstein, and Pathak highlighted key data from the phase 3 NAPOLI 3 trial (NCT04083235) of NALIRIFOX (liposomal irinotecan, 5-fluorouracil [5-FU], leucovorin, and oxaliplatin) vs nab-paclitaxel (Abraxane) and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma; the toxicity profiles of NALIRIFOX and FOLFIRINOX (leucovorin, 5-FU, irinotecan, and oxaliplatin); real-world data with these regimens, and more. 

Ronald Gruner shares how his research—spanning two and a half years—revealed deep divisions within America during the COVID pandemic. From conspiracy theories to the emotional toll on families, his work sheds light on how personal freedoms, death rates, and the economy were all shaped by differing public health policies. Gruner also explains how doctors, nurses, and communities across the country were deeply impacted by what they witnessed.Betsy contributes a deeply personal perspective, recalling the painful goodbye to her brother over a phone video call. She notes the grief that followed when people did not attend his funeral or visit her mother afterward.Betsy also shares the story of a funeral director whose work during the pandemic left lasting impressions.The conversation explores long COVID, which continues to puzzle physicians searching for effective treatments.Gruner emphasizes the importance of seeking information from reputable medical institutions such as Mayo Clinic, Johns Hopkins, and Massachusetts General Hospital.Betsy found COVID WARS to be both informative and compelling, especially the state-by-state demographics that shed light on pandemic outcomes. She highly recommends this book for anyone seeking to understand the profound impact of COVID on American society.Become a supporter of this podcast: https://www.spreaker.com/podcast/chatting-with-betsy--4211847/support.If you are looking for further information or to talk Betsy- Contact:  Betsy Wurtzel -   sloanbetsy31@gmail.com

Send us a textIn this inspiring episode, Anne E. Goldfeld, MD—physician-scientist, humanitarian, and recipient of the 2025 Jimmy and Rosalynn Carter Humanitarian Award—joins Marla Dalton, CAE, and William Schaffner, MD, to reflect on a remarkable career in medicine, science, and global health. From treating patients in refugee camps along the Thai-Cambodian border to conducting groundbreaking research at Harvard Medical School and Boston Children's Hospital, Goldfeld shares the path that led her to a career that is tackling 2 of the greatest epidemics of our time: tuberculosis and HIV/AIDS.Show NotesA native Californian, Dr. Goldfeld attended Brown University and the University of California, Berkeley, and earned her medical degree from Albert Einstein College of Medicine. She completed her internship and residency in internal medicine and a clinical fellowship in infectious diseases at the Massachusetts General Hospital followed by a postdoctoral research training in molecular biology at Harvard University. She is Professor of Medicine and Pediatrics at Harvard Medical School and a Senior Investigator in the Program in Cellular and Molecular Medicine at Boston Children's Hospital, where her research laboratory is located. She is also Professor of Immunology and Infectious Disease at the Harvard TH Chan School of Public Health and a physician in the infectious disease division of Brigham and Women's Hospital. On the frontlines of the TB and AIDS crises, Dr. Goldfeld co founded transformative treatment and research programs—bringing care to some of the world's most underserved populations—that have led to fundamental discoveries that have saved countless lives.Follow NFID on social media

This week, Dr. Fatima Cody Stanford joins us for a compassionate conversation about weight, health, and healing. We're exploring why obesity should be understood as a chronic disease, not a moral failing, and discussing new treatment options like GLP-1 medications that are changing lives. Dr. Stanford is an obesity medicine Physician-Scientist at Massachusetts General Hospital and Harvard Medical School. What makes her perspective so valuable is that she understands the unique experiences of Black women navigating weight and health in a world that often judges us harshly. As one of the few Black women leading research in this field, she sees how chronic stress, systemic barriers, and generational trauma show up in our bodies in ways that traditional medicine has often overlooked. During our conversation, we talk about the science behind weight regulation, how new medications actually work, and why it's time to move beyond BMI as the only measure of health. About the Podcast The Therapy for Black Girls Podcast is a weekly conversation with Dr. Joy Harden Bradford, a licensed Psychologist in Atlanta, Georgia, about all things mental health, personal development, and all the small decisions we can make to become the best possible versions of ourselves. Resources & Announcements Did you know you can leave us a voice note with your questions for the podcast? If you have a question you'd like some feedback on, topics you'd like to hear covered, or want to suggest movies or books for us to review, drop us a message at memo.fm/therapyforblackgirls and let us know what’s on your mind. We just might share it on the podcast. Grab your copy of Sisterhood Heals. Find obesity medicine physicians Where to Find Our Guest Website: https://www.askdrfatima.com Instagram: @askdrfatima LinkedIn: https://www.linkedin.com/in/askdrfatima/ X (Twitter): https://x.com/askdrfatima Stay Connected Join us in over on Patreon where we're building community through our chats, connecting at Sunday Night Check-Ins, and soaking in the wisdom from exclusive series like Ask Dr. Joy and So, My Therapist Said. ​ Is there a topic you'd like covered on the podcast? Submit it at therapyforblackgirls.com/mailbox. If you're looking for a therapist in your area, check out the directory at https://www.therapyforblackgirls.com/directory. Grab your copy of our guided affirmation and other TBG Merch at therapyforblackgirls.com/shop. The hashtag for the podcast is #TBGinSession. Make sure to follow us on social media: Twitter: @therapy4bgirls Instagram: @therapyforblackgirls Facebook: @therapyforblackgirls Our Production Team Executive Producers: Dennison Bradford & Maya Cole Howard Director of Podcast & Digital Content: Ellice Ellis Producers: Tyree Rush & Ndeye Thioubou See omnystudio.com/listener for privacy information.

Bradley Jay Fills in on NightSideWhile marijuana is legal in Massachusetts, it's not legal everywhere across the United States. Studies show that there are some medicinal benefits of marijuana and many use marijuana to treat various ailments like depression and anxiety, epilepsy, chronic pain and more. Should cannabis be federally legal? Dr. Peter Grinspoon, a primary care physician at Massachusetts General Hospital as well as an instructor at Harvard Medical School has 25 years of experience specializing in cannabis medicine joined Bradley to talk about the pros and cons of cannabis.

Today on HBN, we close out Season 9 with a salute to you all, a Grateful Nation, for showing up and supporting the mission of Home Base.We look forward to bringing you new conversations and content in the Fall, and we'll welcome back to the mic, Dr. Ron Hirschberg, as we look to Season 10.On July 26, 2025, 3,000 runners and walkers participated in the 16th annual Run to Home Base, presented by RTX, either in person at historic Fenway Park or virtually around the country. To date, this year's event has raised over $3.6 million - a record-breaking figure for our most critical annual fundraiser - in support of Home Base's mission to heal the invisible wounds of war for Veterans, Service Members, Military Families, and Families of the Fallen at no out-of-pocket cost to them.5 Days left to donate to the Run To Home Base - every dollar counts!  Donate at www.runtohomebase.org.In this episode you'll hear from  Red Sox Broadcaster Tom Caron, who was joined during a Red Sox pregame by Sox pitcher Liam Hendriks and Home Base Captain Kristi Hendriks, both who were guests on this podcast a few episodes ago, as well as Bekah Salwasser of the Red Sox Foundation, and Jack Hammond of the Home Base Program to discuss the impact and importance of the Run to Home Base event.Next, you'll go to the morning of July 26 at Fenway Park for the introductory ceremony for the Run to Home Base.  This year, paying special tribute to Veteran and Service Member First Responders.You'll hear from Tom Werner, Red Sox Chairman; Dr. Richard Carmona, the 17th Surgeon General of the United States; our Executive Director, General Jack Hammond; and an incredible testament to the Home Base Mission and a personal journey in getting his life back - with Army Veteran Ezequiel "Zeek" Grimaldo.Home Base Nation is the official podcast for the Home Base Program for Veterans and Military Families. Our team sees veterans, service members, and their families addressing the invisible wounds of war at no cost. This is all made possible thanks to a grateful nation. For more information on how you can help, please visit us at www.homebase.org. If you or someone you know needs care, you can reach us at 617-724-5202.   Follow Home Base on Twitter, Facebook, Instagram, and LinkedIn   The Home Base Nation Team is Steve Monaco, Army Veteran Kelly Field, Justin Scheinert, Chuck Clough, with COO Michael Allard, Brigadier General Jack Hammond, and Peter Smyth.   Producer and Host: Dr. Ron Hirschberg   Assistant Producer, Editor: Chuck Clough   Chairman, Home Base Media Lab: Peter SmythThe views expressed by guests to the Home Base Nation podcast are their own, and their appearance on the program does not imply an endorsement of them or any entity they represent. Views and opinions expressed by guests are those of the guests and do not necessarily reflect the views of the Massachusetts General Hospital, Home Base, the Red Sox Foundation, or any of its officials.

Tune into the latest podcast from the American Neurological Association (ANA), ANA Investigates: 75 Years of NINDS. This year marks the 75th anniversary of the National Institute of Neurological Disorders and Stroke (NINDS)—an opportunity to reflect on the institute's past achievements and look ahead to the future of neurological research.  This month, ANA Investigates welcomes Dr. Walter Koroshetz, Director of NINDS, in conversation with Dr. Adeline Goss, Neurohospitalist at Highland Hospital. Dr. Koroshetz joined the institute in 2007 as Deputy Director and became Director in 2015. Before joining the NINDS, he served as Vice Chair of Neurology, Director of Stroke and Neurointensive Care Services at Massachusetts General Hospital, and neurologist in the MGH Huntington's Disease Clinic.   Tune in as they discuss highlights from the NINDS's 75-year history and explore what lies ahead for neurological research and innovation. Guest: Walter J. Koroshetz, MD, FANA Director National Institute of Neurological Disorders and Stroke Interviewer: Adeline Goss, MD Neurohospitalist Highland Hospital Disclosures: None

Dr. Richard Kradin, a physician at Massachusetts General Hospital and Harvard Medical School Professor Emeritus, is our guest in this episode. Listen in as Dr. Wendy Patrick and Attorney Larry Dershem interview Dr. Kradin about his new book, A Godless Crusade: The Progressive Campaign to Rid the World of Religion. Why does the left see Judeo-Christian morality as a threat? How have the Progressives managed to infiltrate almost every area of our culture, including our entertainment, schools, corporate boardrooms and even our pulpits? And more importantly, how do we fight back against this hostile takeover and preserve our freedoms, our faith and our families? Find answers to these questions and more in this broadcast. https://defiancepress.com/blog/authors/dr-richard-kradin/See omnystudio.com/listener for privacy information.

Episode 060 | Iris Rubin, MD is the founder of SEEN, a patented, award-winning, science-backed, mission-driven haircare system. At SEEN, it's all about great haircare that won't do damage to your skin.Dr. Rubin received her undergraduate degree with honors from Stanford University, and her medical degree from Harvard Medical School. She did her dermatology residency at the University of Chicago and Harvard Medical School, and served as academic chief resident at Harvard. She completed a laser surgery fellowship at Massachusetts General Hospital and Wellman Center for Photomedicine.Prior to launching SEEN, Dr. Rubin's previous positions include Medical Director of the Dermatologic and Vascular Laser Surgery Program at Children's National Medical Center in Washington D.C., Dermatologist at Massachusetts General Hospital, and a faculty member at Harvard Medical School.Dr. Rubin has been an invited speaker at meetings sponsored by the American Society for Laser Medicine and Surgery (ASLMS), American Academy of Dermatology (AAD), American Society for Dermatologic Surgery (ASDS), Washington D.C. Dermatological Society, and Children's National Medical Center.This episode was recorded on February 3rd, 2025.Connect with and learn from Dr. Rubin and SEENSEENThe Science Behind SEENFind Your SEEN RegimenMore from Dr. Lewellis and Above & Beyond DermatologyNeed a dermatologist? Fill out this short interest form, text or call me at 715-391-9774, or email me at drlewellis@aboveandbeyondderm.com if you'd like to have a no obligation discovery call. I offer in-office visits, house calls, and virtual care in Wisconsin and virtual care in Illinois, Nebraska, and Colorado.Have an idea for a guest or want to be on the show yourself? Send me a text or email, and we'll see if it's a good fit.Above & Beyond DermatologyNutrafol -- special pricing and physician exclusive productsNeoGenesis -- my favorite source of stem cell released molecules for skin/hairSilagen.biz -- physician dispensed scar refinement products delivered to your door (use practice code 1206240832P)NewsletterLinkedInFacebookDr. Lewellis on InstagramAbove & Beyond Dermatology on InstagramYouTubeTikTokTwitter/XChange Your Mind, Change Your LifeSoMeDocs (Doctors on Social Media)Pippa!

In this episode of Get Psyched, we sit down with Dr. J. Stuart Ablon—clinical psychologist, founder of Think:Kids at Massachusetts General Hospital, and Thomas G. Stemberg Endowed Chair in Child and Adolescent Psychiatry at Harvard Medical School. Dr. Ablon has spent decades championing a compassionate, evidence-based approach to challenging behavior called Collaborative Problem Solving (CPS)—a model built on empathy, co-regulation, and the belief that “kids do well if they can.”We explore Dr. Ablon's personal journey, from his early inspirations to his work transforming schools, hospitals, juvenile justice systems, and beyond. He breaks down the core principles of CPS, shares how it can be applied across psychiatry and other disciplines, and offers practical advice for medical students, residents, and clinicians navigating high-stress environments.From dismantling misconceptions about behavior management to addressing systemic inequities, Dr. Ablon invites us to rethink how we understand, and respond to, human behavior. Whether you're a medical student, psychiatrist, educator, or simply curious about new ways to foster connection and change, this conversation will leave you informed, inspired, and ready to collaborate.Links to resources:https://www.stuartablon.com/https://thinkkids.org/Music from #Uppbeat (free for Creators!):https://uppbeat.io/t/cruen/city-streetsLicense code: 2JJVCBQKEE2GJH5N

Breaking Barriers, Making Healthy Choices, and Embracing Survivorship Breaking Barriers, Making Healthy Choices, and Embracing Survivorship. In this episode Yonni and Heather sit down with Dr. Laurie Kirstein from Memorial Sloan Kettering Cancer Center, who made history as the first female chair of the American College of Surgeons' Commission on Cancer. We will talk about breaking glass ceilings, access to quality healthcare, pain management and the impact of smoking on women's health outcomes. Dr. Laurie Kirstein is an Attending Breast Surgeon at memorial string Cancer Center. She attended downstate medical school, Montefiore Medical Center/Albert Einstein University for residency and Massachusetts General Hospital for Breast Surgery fellowship. Prior to arriving at Memorial Sloan Kettering she was attending surgeon and Breast Fellowship Director at the Rutgers Cancer Center Institute of New Jersey. At Memorial SloanKettering she is the Surgical Site Director for their Monmouth, NJ location. She is the current Chair for the American College of Surgeon's Commission on Cancer. She is the lead for the national quality improvement project Breaking Barriers: overcoming barriers to cancer care across America. Her research interests include surgical decision for breast cancer, postoperative pain management and tobacco cessation for cancer patients. Find Yonni & Heather here https://www.herhealthcompass.com/

In this episode of The Healers Café, Manon Bolliger, FCAH, RBHT (facilitator and retired naturopath with 30+ years of practice) speaks to Dr Eva Selhub who discusses the challenges of health and life choices, and how her program aims to educate and support individuals in making better decisions. For part 2 transcript and full story go to: https://www.drmanonbolliger.com/dr-eva-selhub2  For part 1 go to:  https://www.drmanonbolliger.com/dr-eva-selhub/           Highlights from today's episode include: Dr Eva introduced her comprehensive online course, "Foundations of Mastering Resilience," which combines nearly 30 years of clinical and coaching experience, scientific research, and holistic wisdom to help people build resilience in all areas of life. Dr Eva explained the difference between energy and vitality, stressing that vitality is the animating life force that goes beyond just having energy, and that self-awareness of this vitality is essential for true resilience. Manon's insight on the importance of distinguishing between physical, mental, and emotional energy when assessing a person's well-being, and recognizing that vitality—the animating life force—can improve even before physical symptoms do. ABOUT DR. EVA SELHUB: Dr. Eva Selhub is an internationally recognized resiliency expert thought leader, physician, author, executive coach, keynote speaker, and spiritual advisor. With almost three decades of experience, she previously held roles as an Instructor of Medicine at Harvard Medical School and as a Clinical Associate at the prestigious Benson Henry Institute for Mind-Body Medicine at Massachusetts General Hospital, where she also served as Medical Director for six years. Dr. Selhub also served as an adjunct scientist of neuroscience at Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, one of six human nutrition research centers supported by the United States Department of Agriculture (USDA). Dr. Selhub now collaborates with clients and organizations, leveraging her expertise to redefine leadership and wellbeing paradigms. Dr. Selhub possesses a unique talent for distilling complex scientific and spiritual concepts into practical, accessible knowledge. Her transformative energy, intuitive guidance, scientific expertise, and practical mindset inspire profound change and growth in her clients and audiences worldwide.  She is the author of six books, including: Burnout for Dummies, Resilience for Dummies, Your Health Destiny, The Stress Management Handbook, The Love Response.  Additionally, she co-authored:  Your Brain on Nature and has been featured in esteemed publications like The New York Times, authored multiple scientific publications, and has been showcased on national and international media platforms. Core purpose/passion: I want to bring hope to humanity of the infinite possibilities that are available to us to heal and live a full and rich life. That magic can be normal. Website | Facebook | LinkedIn | Instagram | YouTube | TikTok | Twitter   ABOUT MANON BOLLIGER, FCAH, RBHT  As a de-registered (2021) board-certified naturopathic physician & in practice since 1992, I've seen an average of 150 patients per week and have helped people ranging from rural farmers in Nova Scotia to stressed out CEOs in Toronto to tri-athletes here in Vancouver.  My resolve to educate, empower and engage people to take charge of their own health is evident in my best-selling books:  'What Patients Don't Say if Doctors Don't Ask: The Mindful Patient-Doctor Relationship' and 'A Healer in Every Household: Simple Solutions for Stress'.  I also teach BowenFirst™ Therapy through and hold transformational workshops to achieve these goals. So, when I share with you that LISTENING to Your body is a game changer in the healing process, I am speaking from expertise and direct experience". Manon's Mission: A Healer in Every Household!  For more great information to go to her weekly blog:  http://bowencollege.com/blog.  For tips on health & healing go to: https://www.drmanonbolliger.com/tips   Follow Manon on Social – Facebook | Instagram | LinkedIn | YouTube | Twitter | Linktr.ee | Rumble   ABOUT THE HEALERS CAFÉ:  Manon's show is the #1 show for medical practitioners and holistic healers to have heart to heart conversations about their day to day lives.  Subscribe and review on your favourite platform: iTunes | Google Play | Spotify | Libsyn | iHeartRadio | Gaana | The Healers Cafe | Radio.com | Medioq |   Follow The Healers Café on FB: https://www.facebook.com/thehealerscafe   Remember to subscribe if you like our videos. Click the bell if you want to be one of the first people notified of a new release. * De-Registered, revoked & retired naturopathic physician after 30 years of practice in healthcare. Now resourceful & resolved to share with you all the tools to take care of your health & vitality!

Scott is Co-Chief Executive Officer and a co-chair of the firm's Management committee. Scott's current and prior directorships include Thermo Fisher Scientific Corp., Agiliti, the Madison Square Garden Company, Experian, Warner Music Group, Houghton Mifflin Co., Fisher Scientific, Univision Communications, Inc., iHeartMedia, Inc., Front Line Management, The Learning Company, PriCellular Corp., ProcureNet, ProSiebenSat.1, Wyndham Hotels, Federal Street Acquisition Corp. and several other private companies. Prior to joining Thomas H. Lee Partners, Scott was, for more than a decade, managing partner of the affiliate of Harvard Management Company that managed all alternative asset classes for Harvard University's endowment fund. Before that he was a Senior Consultant with the Boston Consulting Group. Scott is involved with a number of charitable and non-profit organizations. He is Chairman of MassGeneralBrigham, the Parent of the Harvard teaching hospitals, Massachusetts General Hospital and Brigham & Women's Hospital as well as a number of leading specialty and community hospitals and physicians practice groups. He is Chairman Emeritus of the CitiCenter for Performing Arts and Wang Theater. He is also a member of each of the Harvard Business School Board of Dean's Advisors, the Harvard University Committee on University Resources and the Harvard Business School's Rock Center for Entrepreneurship.

We are pleased to present this special episode from a podcast headed by our fellow podcaster, friend, and supporter of veterans, Buzz Knight.Buzz has been a force in media, working as a strategist and a media executive for decades. He has an excellent podcast called "Takin' A Walk", a show that focuses on resilience, mental health, and amazing stories through the healing power of music.  We are fortunate to cross-pollinate with Buzz to share an episode of "Takin' A Walk” where he shares an interview with our friend and previous guest on the Home Base Nation Podcast, Mary Gauthier.Mary is a Grammy-nominated singer-songwriter, author, and military family member, as well as a huge supporter of veterans. A New Orleans native, Mary spent many years grappling with spiraling addiction, alcohol, and depression before discovering her gift as a songwriter. Through song, she found that she could express things she was unable to express in other ways and gained new confidence through writing and performing.  She has co-written songs with veterans through the Songwriting with Soldiers program.If you would like to hear more episodes of ‘Takin' A Walk,' visit the archives at takinawalk.com.Home Base Nation is the official podcast for the Home Base Program for Veterans and Military Families. Our team sees veterans, service members, and their families addressing the invisible wounds of war at no cost. This is all made possible thanks to a grateful nation. To learn more about how to help, visit us at www.homebase.org. If you or anyone you know would like to connect to care, you can also reach us at 617-724-5202.Follow Home Base on Twitter, Facebook, Instagram, LinkedInThe Home Base Nation Team is Steve Monaco, Army Veteran Kelly Field, Justin Scheinert, Chuck Clough, with COO Michael Allard, Brigadier General Jack Hammond, and Peter Smyth.Producer and Host: Dr. Ron HirschbergAssistant Producer, Editor: Chuck CloughChairman, Home Base Media Lab: Peter SmythThe views expressed by guests on the Home Base Nation podcast are their own, and their appearance on the program does not imply an endorsement of them or any entity they represent. Views and opinions expressed by guests are those of the guests and do not necessarily reflect the views of the Massachusetts General Hospital, Home Base, the Red Sox Foundation, or any of its officials.

Pregnancy with type 1 diabetes requires tight management—but what if the very tools designed to help aren't designed or approved for pregnancy? We're talking about the T1D Pregnancy & Me study, a groundbreaking effort to close the data gap and include pregnant women in diabetes tech research. We'll go through who can be in this study, how It works, what they're looking for and what it could mean for the future of diabetes care during those nine months and a lot more. My guests are: Dr Camille E. Powe, an Associate Professor at Massachusetts General Hospital and Harvard Medical School and the study's Chair and Carrie Matuzsan, a patient advisor. Carrie lives with type 1 and had twins in 2020. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Learn more about the study here Join us at an upcoming Moms' Night Out event! Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom  Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.

We have published 120 episodes since 2019. For this new season, we thought it would be a good idea to look back on some of the highlights of our conversations and select 20 episodes that resonated with veterans, service members, military families, and the civilians who support them.But first up, you'll hear from some of the folks at Home Base who wake up every day with the same mission in mind, no matter what they do at the Center of Excellence in the Navy Yard and beyond. For this episode, you will hear a brief conversation with Air Force Veteran and Regional Associate Director, Regional & Tribal Relations, of Home Base Arizona, Marcus Denetdale. Marcus has been instrumental in facilitating Home Base's partnership with ASU's College of Health Solutions to launch the Warrior Health & Fitness program for Arizona Veterans and their families. He has worked closely with tribal Nations and communities in various capacities. As a nonprofit administrator, he has developed college scholarship programs, recruited Native American college students, and secured research grants for higher education projects totaling over $2.4 million. Marcus has studied civil, environmental, & sustainable engineering within the sustainability specialty area. His research areas include tribal housing, infrastructure & commercial buildings for economic growth and opportunities. His latest project is partnered with ASU to provide safe water access on the Navajo Nation.Following my conversation with Marcus, you'll hear part two of an episode from 2023 with the Pulitzer Prize and Emmy winner Cartoonist, Garry Trudeau. Ron and Garry talk about gaining the trust from military leadership during wartime, with the opportunity to visit Kuwait during the Gulf War after getting the call directly from the battlefield, and how just like visiting Walter Reed, these are chances to Get it Right in order to follow him or her from service member to veteran and from deployment to home. They discuss how he's not really that guy who could ever really tell a joke, and where his humor seems to come from, about his love for putting on a show ever since he was a little kid, and how he shares the mission to support veterans with fellow cartoonist (among other things), Jake Tapper.Run To Home Base: Join Ron and his team and sign up individually or on another team at the 16th annual Run To Home Base on July 26th, 2025, at Fenway Park! Go to runtohomebase.orgPlease visit homebase.org for updates, programming, and resources if you or someone you know is struggling.Home Base Nation is the official podcast for the Home Base Program for Veterans and Military Families. Our team sees veterans, service members, and their families addressing the invisible wounds of war at no cost. This is all made possible thanks to a grateful nation. To learn more about how to help, visit us at www.homebase.org. If you or anyone you know would like to connect to care, you can also reach us at 617-724-5202.Follow Home Base on Twitter, Facebook, Instagram, LinkedInThe Home Base Nation Team is Steve Monaco, Army Veteran Kelly Field, Justin Scheinert, Chuck Clough, with COO Michael Allard, Brigadier General Jack Hammond, and Peter Smyth.Producer and Host: Dr. Ron HirschbergAssistant Producer, Editor: Chuck CloughChairman, Home Base Media Lab: Peter SmythThe views expressed by guests on the Home Base Nation podcast are their own, and their appearance on the program does not imply an endorsement of them or any entity they represent. Views and opinions expressed by guests are those of the guests and do not necessarily reflect the views of the Massachusetts General Hospital, Home Base, the Red Sox Foundation, or any of its officials.

More than a thousand AI medical devices have FDA clearance, yet fewer than two percent of radiologists actually use them.In this episode, Steve sits down with Dr. Brian Anderson—CEO and co‑founder of the Coalition for Health AI—to unpack why trust, transparency, and regulation could make or break the next wave of AI‑powered medicine.We cover:

We have published 120 episodes since 2019. For this new season, we thought it would be a good idea to look back on some of the highlights of our conversations and select 20 episodes that resonated with veterans, service members, military families, and the civilians who support them.But first up, you'll hear from some of the folks at Home Base who wake up every day with the same mission in mind, no matter what they do at the Center of Excellence in the Navy Yard and beyond. For this episode, you will hear a brief conversation with the Admissions Coordinator at Home Base, Zachary Morin. Born and raised in Massachusetts, Zach spent two years serving with AmeriCorps in the Miami-Dade Public Schools, working with middle school students on literacy, social and emotional development, as well as civic engagement. Upon completing his service, Zachary returned to New England to lead the College Ready Communities program in Northern Rhode Island. Here, his work included holistic programming for vulnerable youth populations and overall community engagement initiatives. He also has a creative/performative side, which he will talk about.Following my conversation with Zach, you'll hear an episode from 2023 with the Pulitzer Prize and Emmy-winning cartoonist, Garry Trudeau. Garry is also an Army Commander's Award for Public Service honoree. In this conversation, Garry tells us that not only did his dad and grandfather both serve, but they were also both physicians. He recounts an eye-opening visit to Walter Reed Medical Center, with stories of injury and resilience that not only informed his storytelling but have had lasting impacts on him. As a big fan of author Sebastian Junger, he discusses the innate need for the tribe to survive, and explains a bit of his creative process. Part Two will come shortly.Run To Home Base: Join Ron and his team and sign up individually or on another team at the 16th annual Run To Home Base on July 26th, 2025, at Fenway Park! Go to runtohomebase.orgPlease visit homebase.org for updates, programming, and resources if you or someone you know is struggling.Home Base Nation is the official podcast for the Home Base Program for Veterans and Military Families. Our team sees veterans, service members, and their families addressing the invisible wounds of war at no cost. This is all made possible thanks to a grateful nation. To learn more about how to help, visit us at www.homebase.org. If you or anyone you know would like to connect to care, you can also reach us at 617-724-5202.Follow Home Base on Twitter, Facebook, Instagram, LinkedInThe Home Base Nation Team is Steve Monaco, Army Veteran Kelly Field, Justin Scheinert, Chuck Clough, with COO Michael Allard, Brigadier General Jack Hammond, and Peter Smyth.Producer and Host: Dr. Ron HirschbergAssistant Producer, Editor: Chuck CloughChairman, Home Base Media Lab: Peter SmythThe views expressed by guests on the Home Base Nation podcast are their own, and their appearance on the program does not imply an endorsement of them or any entity they represent. Views and opinions expressed by guests are those of the guests and do not necessarily reflect the views of the Massachusetts General Hospital, Home Base, the Red Sox Foundation, or any of its officials.

Dr Jeremy Abramson from Massachusetts General Hospital in Boston, Dr Joshua Brody from the Tisch Cancer Institute in New York, New York, Dr Christopher Flowers from The University of Texas MD Anderson Cancer Center in Houston, Dr Ann LaCasce from Dana-Farber Cancer Institute in Boston, Massachusetts, and Dr Tycel Phillips from City of Hope Comprehensive Cancer Center in Duarte, California, discuss patient cases and provide their perspectives on clinical datasets informing the care of patients with non-Hodgkin lymphoma. CME information and select publications here.

We have published 120 episodes since 2019. For this new season, we thought it would be a good idea to look back on some of the highlights of our conversations and select 20 episodes that resonated with veterans, service members, military families, and the civilians who support them.But first up, you'll hear from some of the folks at Home Base who wake up every day with the same mission in mind, no matter what they do at the Center of Excellence in the Navy Yard and beyond. If you are just tuning in to the show, our host, Dr. Ron Hirschberg, and I have reviewed more than 120 published episodes since 2019. We chose 20 or so to share with you again that resonated with veterans, service members, military families, and the civilians who support them.For this episode, you will hear a brief conversation with Dr. Drew Teer who completed his PhD in clinical psychology from Emory University, where he also finished his internship at Emory University's School of Medicine at Grady Memorial Hospital as well as his postdoctoral fellowship with the Emory Healthcare Veterans Program – one of the other Warrior Care Network sites. Drew is passionate about providing science-based treatments for PTSD and other internalizing disorders. His research interests include identifying factors that may influence responses to PTSD treatment and enhancing treatments for underserved and complex trauma populations.Following my conversation with Dr. Teer, you'll hear an episode with 7-time nominated and 2-time Grammy winner and Marine Veteran, Shaggy. For Shaggy, music has been a vehicle to bring different kinds of people together for a shared experience. But it's not just the music that does this; it's his spirit and grit, which were undoubtedly shaped by his Marine background.Run To Home Base: Join Ron and his team and sign up individually or on another team at the 16th annual Run To Home Base on July 26th, 2025, at Fenway Park! Go to runtohomebase.orgPlease visit homebase.org for updates, programming, and resources if you or someone you know is struggling.Home Base Nation is the official podcast for the Home Base Program for Veterans and Military Families. Our team sees veterans, service members, and their families addressing the invisible wounds of war at no cost. This is all made possible thanks to a grateful nation. To learn more about how to help, visit us at www.homebase.org. If you or anyone you know would like to connect to care, you can also reach us at 617-724-5202.Follow Home Base on Twitter, Facebook, Instagram, LinkedInThe Home Base Nation Team is Steve Monaco, Army Veteran Kelly Field, Justin Scheinert, Chuck Clough, with COO Michael Allard, Brigadier General Jack Hammond, and Peter Smyth.Producer and Host: Dr. Ron HirschbergAssistant Producer, Editor: Chuck CloughChairman, Home Base Media Lab: Peter SmythThe views expressed by guests on the Home Base Nation podcast are their own, and their appearance on the program does not imply an endorsement of them or any entity they represent. Views and opinions expressed by guests are those of the guests and do not necessarily reflect the views of the Massachusetts General Hospital, Home Base, the Red Sox Foundation, or any of its officials.

Dean's Chat hosts, Drs. Jensen and Richey, welcome Dr. Adam Landsman to Dean's Chat! Adam Landsman, DPM, PhD, FACFAS is an Assistant Professor of Orthopedic Surgery at the Harvard University School of Medicine, and Lead Podiatrist in the Department of Orthopedics at the Massachusetts General Hospital in Boston.  Dr. Landsman is Board Certified in Foot Surgery by the American Board of Foot and Ankle Surgery. He holds a PhD in Bioengineering in addition to his Podiatric Medicine Degree.  Dr. Landsman has completed over 30 clinical trials, holds 2 patents, and has published 90+ peer-reviewed studies and numerous book chapters. Previously, he served as the Director of Podiatric Research at the Scholl College of Podiatric Medicine, and at Samuel Merritt University. He has lectured extensively in the United States and internationally and has held faculty appointments at Northwestern University, University of Miami, and Harvard University. Enjoy this wonderful, entertaining discussion on paving new paths, inventing new products, and paving the way in research for future generations of podiatrists!

In the corner of the ICU, on multiple pressors, distended, oliguric, and intubated you'll find the necrotizing pancreatitis patient. Sounds intimidating, but with the persistence, patience, and the proper care these patients can make it! In this episode from the HPB team at Behind the Knife listen in as we discuss the Step-Up approach, when to surgically intervene, various approaches to pancreatic Necrosectomy, and additional aspects of the multidisciplinary care required for the successful treatment of necrotizing pancreatitis.  Hosts Anish J. Jain MD (@anishjayjain) is a current PGY3 General Surgery Resident at Stanford University and a former T32 Research Fellow at the University of Texas MD Anderson Cancer Center. Jon M. Harrison is a 2nd year HPB Surgery Fellow at Stanford University. He will be joining as faculty at the Massachusetts General Hospital in Boston, MA at the conclusion of his fellowship in July 2024.    Learning Objectives ·      Develop an understanding of the severity of necrotizing pancreatitis and the proper indications to surgical intervene on this often-tenuous patients.  ·      Develop an understanding of the Step-Up approach and key aspects (reimaging, clinical status, physiologic status, etc.) that determine when to “step-up” treatment for patients with necrotizing pancreatitis. ·      Develop an understanding of long term sequalae and complications associated with necrotizing pancreatitis and operative management ·      Develop an understanding of multidisciplinary care and long-term follow-up necessary for adequate treatment of patients suffering from necrotizing pancreatitis. Suggested Reading Maurer LR, Fagenholz PJ. Contemporary Surgical Management of Pancreatic Necrosis. JAMA Surg. 2023;158(1):81–88. doi:10.1001/jamasurg.2022.5695 https://pubmed.ncbi.nlm.nih.gov/36383374/ Harrison JM, Day H, Arnow K, Ngongoni RF, Joseph A, Aldridge T, Wheeler KJ, DeLong JC, Bergquist JR, Worth PJ, Dua MM, Friedland S, Park W, Eldika S, Hwang JH, Visser BC. What's Behind it all: A Retrospective Cohort Study of Retrogastric Pancreatic Necrosis Management. Ann Surg. 2024 Sep 3. doi: 10.1097/SLA.0000000000006521. https://pubmed.ncbi.nlm.nih.gov/39225420/ Harrison JM, Visser BC. Not Dead Yet: Managing the Abdominal Catastrophe in Necrotizing Pancreatitis. Pancreas. 2025 May 20. doi: 10.1097/MPA.0000000000002512. https://pubmed.ncbi.nlm.nih.gov/40388698/ Harrison JM, Li AY, Sceats LA, Bergquist JR, Dua MM, Visser BC. Two-Port Minimally Invasive Nephrolaparoscopic Retroperitoneal Debridement for Pancreatic Necrosis. J Am Coll Surg. 2024 Dec 1;239(6):e7-e12. doi: 10.1097/XCS.0000000000001152. https://pubmed.ncbi.nlm.nih.gov/39051721/ van Santvoort HC, Besselink MG, Bakker OJ, Hofker HS, Boermeester MA, Dejong CH, van Goor H, Schaapherder AF, van Eijck CH, Bollen TL, van Ramshorst B, Nieuwenhuijs VB, Timmer R, Laméris JS, Kruyt PM, Manusama ER, van der Harst E, van der Schelling GP, Karsten T, Hesselink EJ, van Laarhoven CJ, Rosman C, Bosscha K, de Wit RJ, Houdijk AP, van Leeuwen MS, Buskens E, Gooszen HG; Dutch Pancreatitis Study Group. A step-up approach or open necrosectomy for necrotizing pancreatitis. N Engl J Med. 2010 Apr 22;362(16):1491-502. doi: 10.1056/NEJMoa0908821. https://pubmed.ncbi.nlm.nih.gov/20410514/ Bang JY, Arnoletti JP, Holt BA, Sutton B, Hasan MK, Navaneethan U, Feranec N, Wilcox CM, Tharian B, Hawes RH, Varadarajulu S. An Endoscopic Transluminal Approach, Compared With Minimally Invasive Surgery, Reduces Complications and Costs for Patients With Necrotizing Pancreatitis. Gastroenterology. 2019 Mar;156(4):1027-1040.e3. doi: 10.1053/j.gastro.2018.11.031. https://pubmed.ncbi.nlm.nih.gov/30452918/ Zyromski NJ, Nakeeb A, House MG, Jester AL. Transgastric Pancreatic Necrosectomy: How I Do It. J Gastrointest Surg. 2016 Feb;20(2):445-9. doi: 10.1007/s11605-015-3058-y. https://pubmed.ncbi.nlm.nih.gov/26691148/ Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

  In this Rheumatology Rafael Medina Subspecialty episode, Dr. Ana Valle presents a case of Joint pain and skin rash to Dr. Eli Miloslavsky.  Session facilitator: Rahul Pottabathini Case Discussant: Dr. Eli Miloslavsky is a rheumatologist and Associate Professor of Medicine at the Massachusetts General Hospital and Harvard Medical School. Dr. Eli’s Career has been… Read More »Episode 405- Rafael Medina Subspecialty Episode- Joint pain, rash and dry mouth

The goal of this mini series is to spark conversations of these new tools and practices within the community of current and future medical practitioners and staff. It is important for medical professionals to have a say in how these Al tools impact practice to ensure practical and ethical use. Join us in discussions of the history of Al, machine and deep learning. computer visions, natural language processing, responsible Al, and so much more. Let's take a step into the future together.Joining us is Jonathan Theros, Co-Founder and CEO of Dendritic Health AI. A recent MD/MBA graduate from Northwestern University and incoming internal medicine resident at Massachusetts General Hospital, Jon founded his company to address gaps in medical education by developing AI tools that help medical students learn more effectively and prepare for clinical practice. In our conversation, we discussed the future of AI in medical education, the specific tools his startup is building, and how physician entrepreneurs can amplify their impact by supporting the next generation of medical professionals.Dendritic Health AI and Neural Consult:https://www.dendritichealth.comhttps://www.neuralconsult.comEpisode produced by: Caleb Keng & Rohan SethiEpisode recording date: May 15, 2025www.medicuspodcast.com | medicuspodcast@gmail.com | Donate: http://bit.ly/MedicusDonate

My conversation with Dr Dua begins at about 35 mins Stand Up is a daily podcast. I book,host,edit, post and promote new episodes with brilliant guests every day. This show is Ad free and fully supported by listeners like you! Please subscribe now for as little as 5$ and gain access to a community of over 750 awesome, curious, kind, funny, brilliant, generous souls Healthcare For Action was founded in 2022 to support healthcare workers running for Congress. Dr. Anahita Dua, Chair of Healthcare for Action, is a Vascular Surgeon at Massachusetts General Hospital and an Associate Professor of Surgery at Harvard University. As a surgeon, she knows that in order to get things done and save lives, the surgery team has to work together and take action. Our politics shouldn't be any different.  In 2023, Healthcare For Action merged with Doctors In Politics, founded in 2020 by a group of physicians specializing in psychiatry, family medicine, OBGYN, and neurology. They were committed to patient-centered and equitable political change at all levels of government and grew to a membership of nearly 10,000. We believe fundamentally that all policy is health policy.  There are too many existential threats facing our democracy. From reversing climate change, preserving access to abortion, and curbing the epidemic of gun violence we must take action now and play the long game. From acute care to prevention, healthcare workers know how to get the job done. That is the guiding vision of the largest Democratic healthcare workers PAC in the country - Join our community at Healthcare For Action! Anahita Dua, MD, MS, MBA, FACS, is a vascular surgeon at Massachusetts General Hospital and an associate professor of Surgery at Harvard Medical School. At Mass General, she is the director of the Vascular Lab, co-director of the Peripheral Artery Disease Center and Limb Evaluation and Amputation Program (LEAPP), associate director of the Wound Care Center, director of the Lymphedema Center and associate director of the Vascular Surgery Clerkship and director of clinical research for the division of vascular surgery. She specializes in advanced endovascular (minimally invasive) and traditional (open) limb salvage techniques for treating peripheral arterial disease and critical limb ischemia, diabetic limb disease, aortic disease, carotid disease, thoracic outlet syndrome and venous disease. Dr. Dua completed her vascular surgery fellowship at Stanford University Hospital, her general surgery residency at the Medical College of Wisconsin and her medical school in the United Kingdom. She has also completed a master's degree in trauma sciences, a master's in business administration in health care management and has a certificate in health economics and outcomes research as well as a certificate in drug and device development from the Massachusetts Institute of Technology. She is board-certified in vascular surgery, general surgery and advanced wound care and management. Dr. Dua has published over 140 peer reviewed papers and has edited five vascular surgery medical textbooks. She serves on multiple national vascular surgery committees through the Society for Vascular Surgery and other vascular organizations including the South Asian-American Vascular Society and American College of Surgeons. Dr. Dua's lab focuses on anticoagulation and biomarkers that are predictive of thrombosis and hemostasis in patients that have undergone revascularization. She is interested in creation precision, point of care medical approaches to anticoagulation for patients post revascularization. Her clinical and outcomes research focuses primarily on diseases involving peripheral vascular disease, limb salvage and critical limb ischemia. She is part of a technology development team that creates tools to increase walking distance and wound healing while decreasing pain in patients with peripheral vascular disease. Dr. Dua is also involved heavily in surgical outcomes-based research using large medical databases to generate both quality outcomes and cost effectiveness data. Dr. Dua is a self-described animal lover and rescuer of pitbulls. At one point, she housed 14 pitbull puppies and their mother at once. Nowadays, her spare time is spent with her husband, son, daughter and dog Leo. Join us Monday and Thursday's at 8EST for our  Bi Weekly Happy Hour Hangout!  Pete on Blue Sky Pete on Threads Pete on Tik Tok Pete on YouTube  Pete on Twitter Pete On Instagram Pete Personal FB page Stand Up with Pete FB page All things Jon Carroll  Follow and Support Pete Coe Buy Ava's Art  Hire DJ Monzyk to build your website or help you with Marketing  

It's summer and that means slathering yourself with sunblock before you're allowed to go run around outside. Not everyone loves that ritual: sunscreen can be cold or sticky. Sometimes it gets in your eyes, and it always feels like it's time to reapply JUST as you're about to jump in the water or go kick the ball. So, what's the deal? Is it really all that important? We get the scoop from Dr. Jeff Yu, a pediatric dermatologist at Massachusetts General Hospital. He'll help us understand: What is a sunburn? What's a tan? How does sunscreen work? How do you protect your eyes?Download our learning guides: PDF | Google Slide | Transcript

First up on the podcast, Staff Writer Erik Stokstad talks with host Sarah Crespi about how scientists are probing the world's hottest forests to better understand how plants will cope with climate change. His story is part of a special issue on plants and heat, which includes reviews and perspectives on the fate of plants in a warming world.   Next on the show, “convergent” antibodies may underlie the growing number of people allergic to peanuts. Sarita Patil, co-director of the Food Allergy Center at Massachusetts General Hospital and assistant professor at Harvard Medical School, joins the podcast to discuss her research on allergies and antibodies. She explains how different people appear to create antibodies with similar gene sequences and 3D structures that react to peanut proteins—a big surprise given the importance of randomness in the immune system's ability to recognize harmful invaders.   This week's episode was produced with help from Podigy.   About the Science Podcast   Authors: Sarah Crespi; Erik Stokstad Learn more about your ad choices. Visit megaphone.fm/adchoices